GLP-1 medications work by reducing appetite and slowing digestion, and, as a result, many people who use GLP-1 agonists as part of their weight-loss journey eat less
Only certain oral formulations are FDA-approved (for example, Rybelsus for diabetes), and many oral products sold as drops are compounded, not FDA-approved, and lack the clinical testing required to confirm safety and dose
As Kannt & Pfenninger highlight in Frontiers in Physiology , maintaining NAD levels is a cornerstone of metabolic health, supporting mitochondrial function and improving resistance to metabolic stress (Kannt & Pfenninger, Frontiers in Physiology )
While GLP-1 drugs were initially used for diabetes, they are now an increasingly popular category of medication used for weight loss
No claims are made or implied regarding weight loss, metabolic benefits, therapeutic results, or human use
5 For diabetes at least, GLP-1s may therefore be cost-neutral to health funders